2,2′-Dibromodiethyl ether

We are 2,2′-Dibromodiethyl ether CAS:5414-19-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,2'-Dibromodiethyl ether
CAS.NO:5414-19-7
Synonyms:2,2'-Dibromodiethyl Ether
Ethane, 1,1‘-oxybis[2-bromo-
1-bromo-2-(2-bromoethoxy)ethane
2-Bromoethyl ether
2,2-Dibromodiethyl Ether
Molecular Formula:C4H8Br2O
Molecular Weight:231.91400
 
Physical and Chemical Properties:
Density:1.845
Boiling point:92-93ºC
Flash point:185°F
Index of Refraction:1.513
 
Specification:
Appearance:Colorless transparent liquid
Assay(GC):≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2,2'-Dibromodiethyl ether


Related News: Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.2-fluorobencilamina CAS:89-99-6 However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them.1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino)-2,4(1H,3H)-pyrimidinedione CAS:130634-04-7 The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.106261-64-7 As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured.As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.

Related Products
Product Name
1-Pentanethiol View Details
1-(trichloromethyl)-3-(trifluoromethyl)benzene View Details
2,6-dibromo-5-fluoropyridin-3-amine View Details
4,6-Dichloropyrimidine manufacturer 2-Chloro-1-((3-fluorobenzyl)oxy)-4-nitrobenzene manufacturer D-Lysine Monohydrochloride manufacturer 4,4′-Diiodobiphenyl manufacturer 7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid manufacturer